title: [Therapy of osteoporosis: towards personalized treatment?].
abstract: Osteoporosis is the most common clinical disorder of bone metabolism. With regard to the growing spectrum of therapy options, treatment decisions should be made on an individual basis, taking into account the relative benefits and risks in different patient populations. Prioritization of drugs should be based on the form (primary / secondary) and severity of osteoporosis, sex, age, the specific contraindications and precautions of use of the various available medications and in particular, existing comorbidities.
authors.affiliation: Medizinische Klinik 1, UKSH Campus Lübeck.
authors.forename: Birgit
authors.initials: B
authors.lastname: Harbeck
authors.affiliation: Präsidium der Universität zu Lübeck.
authors.forename: Hendrik
authors.initials: H
authors.lastname: Lehnert
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D005260:Female; D005858:Germany / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy* / Q000453:epidemiology*; D057285:Precision Medicine; D015995:Prevalence; D012189:Retrospective Studies
chemical_list: D050071:Bone Density Conservation Agents